SRPK1 and prostate cancer: In our recently published study, we found that increased SRPK1–SRSF1 axis activity in prostate cancer led to preferential splicing of pro‐angiogenic VEGF‐A mRNA, thereby implicating modulation of angiogenesis as an important mechanism in the pathogenesis of this cancer subtype 6 (Figure 1).